Journal
ACTA BIOMATERIALIA
Volume 1, Issue 4, Pages 461-470Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.actbio.2005.03.002
Keywords
heparin; poly(ethylene glycol); fibroblast growth factor; human mesenchymal stem cells; osteogenesis
Funding
- NIAMS NIH HHS [AR44375-02] Funding Source: Medline
Ask authors/readers for more resources
Heparin was modified with methacrylate groups, copolymerized with dimethacrylated poly(ethylene glycol), and analyzed as a localized delivery vehicle for bFGF and synthetic extracellular matrix for the differentiation of hMSCs. By deriving cues from molecules normally present in the extracellular matrix (ECM), a complex network of collagens, laminin, fibronectin, glycosaminoglycans, and growth factors, synthetic cell scaffolds can be designed that actively sequester important bioactive signals. Among the glycosaminoglycans, heparin binds reversibly with many proteins, therefore,. poly(ethylene glycol) based biomaterials, normally resistant to cell adhesion, functionalized with heparin in order to sequester important proteins, can actively and selectively Stimulate desired cell functions. Results demonstrate that methacrylate-modified heparin retained its ability to bind heparin-binding proteins both in solution and when copolymerized with dimethacrylated PEG in a hydrogel. In addition, the heparin functionalized gels can deliver biologically active bFGF for up to 5 weeks. Finally,. the gels were examined as a potential scaffold for hMSC Culture and were found to promote adhesion, proliferation, and osteogenic differentiation. (c) 2005 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available